3 Firms Build Novo Nordisk's $1.8B Emisphere Buy
Global health care company Novo Nordisk inked a total $1.8 billion agreement to buy biotechnology company Emisphere Technologies, the companies said Friday, in a deal put together with help from Wachtell, WilmerHale...To view the full article, register now.
Already a subscriber? Click here to view full article